16:47 EST Axsome Therapeutics (AXSM) files automatic mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXSM:
- Axsome Therapeutics: Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Axsome Therapeutics: Strong Financial Performance and Strategic Advancements Justify Buy Rating
- Axsome Therapeutics Reports 63% Revenue Growth in Q3 2025
- Axsome Therapeutics reports Q3 EPS (94c), consensus (90c)
- Is AXSM a Buy, Before Earnings?